Clinical Trial Update: Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating dronabinol as an adjunct for endometriosis-related pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Endometriosis, Endometriosis Related Pain | Phase 2 | Status: WITHDRAWN